Haemonetics Corporation

符号: HAE

NYSE

91.5

USD

今天的市场价格

36.7000
市盈率
0.2197
PEG比率
4.65B
MRK市值
0.00%
DIV收益率

Haemonetics Corporation (HAE) 财务报表

Q: 什么是 Haemonetics Corporation (HAE) 总资产是多少？

Haemonetics Corporation (HAE) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Haemonetics Corporation (HAE). 的默认数据。公司收入显示 565.328 M 的平均值，即 0.065 % 增长率。整个期间的平均毛利润为 284.179 M，即 0.051 %. 平均毛利率为 0.530 %. 公司去年的净收入增长率为 1.661 %，等于 0.127 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Haemonetics Corporation 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.040. 在流动资产领域，HAE 的报告货币为769.722. 这些资产中的很大一部分，即 284.466 是现金和短期投资。与去年的数据相比，该部分的变化率为0.096%. 公司的长期投资虽然不是其重点，但以报告货币计算的0（如果有的话）为0。这表明与上一报告期相比，0.000% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 754.102. 这一数字表明，-0.010% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 817.997. 这方面的年同比变化率为 0.092%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为179.142，存货估值为 259.38，商誉估值为 466.23（如有. 无形资产总额（如果有）按 275.77 估值. 应付账款和短期债务分别为 63.93 和 11.78. 债务总额为765.89，债务净额为 481.42. 其他流动负债为 145.89，加上总负债 1116.83. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
balance-sheet.row.cash-and-short-term-investments	1115.17	284.5	259.5	192.3	137.3	169.4	180.2	139.6	115.1	160.7	192.5	179.1	228.9	196.7	141.6	156.7	133.6	229.2	250.7	185.8	118.1	49.9	67.5	74.5	61.3	56.3	21.8	8.3	13.4	4.2	16.2	10.3	2.9
balance-sheet.row.short-term-investments	7.27	1.1	0	0	0	0	0	0.1	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	32.6	33	8	12.3	11.9	13.6	0	0	0	0	0
balance-sheet.row.net-receivables	742.12	179.1	159.4	127.6	165.2	185	151.2	152.7	157.1	145.8	165	170.1	135.5	127.2	118.7	113.6	120.3	91.8	86.9	80.7	82.6	77.9	63.7	59.8	59.1	63	58.9	72.2	60.3	63.3	47.5	38.8	33.4
balance-sheet.row.inventory	1138.44	259.4	293	322.6	270.3	194.3	160.8	176.9	186.1	211.1	197.7	183.8	117.2	84.4	80	76.5	65.4	61.8	54.6	53.1	52.2	65.8	67.2	54	59.8	59.8	61.7	55.1	56.7	60	41.3	30.3	30.6
balance-sheet.row.other-current-assets	206.33	46.7	44.1	51.1	30.8	27.4	29	40.9	28.8	50.4	74.6	64	45.1	40.6	33.5	35.6	40.2	20.8	26.3	24	1.9	2.7	2.8	5.7	29.6	52.2	48.8	32.1	28.5	30.1	25.1	16.1	11.6
balance-sheet.row.total-current-assets	3202.05	769.7	756	693.5	603.6	576.1	521.2	510	487.2	568	629.6	597	526.6	448.8	373.7	382.4	359.4	403.7	418.4	343.6	281.4	223.3	232.8	219.2	209.9	231.3	191.2	167.7	158.9	157.6	130.1	95.5	78.5
balance-sheet.row.property-plant-equipment-net	1241.78	310.9	258.5	217.6	253.4	344	332.2	323.9	337.6	321.9	271.4	257	161.7	155.5	153.3	137.8	116.5	90.8	75.3	69.3	78	84	84.9	83.3	81.6	83	84.2	103.6	86.4	82.1	68.3	56	46.8
balance-sheet.row.goodwill	1952.55	466.2	467.3	466.4	210.7	210.8	211.4	210.8	267.8	334.3	336.8	330.5	115.1	115.4	120.5	56.4	54.2	35	18.5	0	0	0	14.2	14.4	1.8	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1223.69	275.8	310.3	365.5	133.1	127.7	156.6	177.5	204.5	244.6	271.2	264.4	96.5	101.8	86.1	65.3	64.3	33.9	22.9	44	42	42.3	24.2	15.8	1.8	10.5	10.7	10.3	0	0	9.3	7.6	6.9
balance-sheet.row.goodwill-and-intangible-assets	3176.24	742	777.5	831.9	343.8	338.5	368	388.4	472.3	578.9	607.9	594.9	211.6	217.2	206.6	121.7	118.6	68.8	41.4	44	42	42.3	38.4	30.3	1.8	10.5	10.7	10.3	0	0	9.3	7.6	6.9
balance-sheet.row.long-term-investments	-4.64	0	0	-6	-3.9	-4.4	-4	-4	-7.1	-581.9	-609.1	-596.6	-211.6	0	-211.6	0	0	0	0	0	0	0	3.2	0	10.8	24.7	38.6	31	0	0	0	0	0
balance-sheet.row.tax-assets	19.93	5.2	4.5	6	3.9	4.4	4	4	7.1	3	1.2	1.8	0	1.3	4.9	3	9.2	4.5	1.2	0.1	0	3	2.3	1.7	10.7	11.7	9.9	12.8	0	0	0	0	0
balance-sheet.row.other-non-current-assets	473.43	107	63.2	76.9	66.3	16.2	16	16.4	20	593.2	619.8	608	222.3	10.5	227.2	4.8	5.2	5	10.2	10.7	5.9	6.7	3.4	10.9	34.3	-4.8	2.1	-1.9	42.5	40.8	23	21.2	12.6
balance-sheet.row.total-non-current-assets	4906.73	1165.1	1103.7	1126.4	663.5	698.6	716.2	728.7	829.9	915.1	891.2	864.9	384	384.4	380.5	267.3	249.5	169.1	128.1	124.1	125.9	136	132.1	126.2	139.2	125.1	145.5	155.8	128.9	122.9	100.6	84.8	66.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	8108.79	1934.8	1859.7	1819.9	1267.1	1274.8	1237.3	1238.7	1317.1	1483.1	1520.8	1461.9	910.6	833.3	754.1	649.7	609	572.7	546.5	467.8	407.4	359.2	364.9	345.3	349.1	356.4	336.7	323.5	287.8	280.5	230.7	180.3	144.8
balance-sheet.row.account-payables	279.07	63.9	58.4	50.3	50.7	63.4	55.3	43	39.7	48.4	53.6	49.9	35.4	28.3	25.6	20.7	19.7	17.2	14.2	11.1	14.2	13.7	12.5	13.3	17.2	10.7	21.7	27.9	16.9	15.6	14.7	13.2	9.1
balance-sheet.row.short-term-debt	52.66	11.8	214.1	17	77	27.7	194.3	61	43.5	21.5	45.6	23.1	0.9	0.9	17.1	0.7	6.3	22.2	26.2	26.6	32.8	39	31.4	22.4	32.9	6.6	17.5	19.5	3.4	8.3	4.5	3	8.4
balance-sheet.row.tax-payables	0	0	13.9	23.7	16.6	12.4	8.3	8.5	5.2	8	10.2	9.2	8.1	6	5.1	2.8	5.3	1.2	10.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	3110.99	754.1	559.4	690.6	305.5	322.5	59.4	253.6	364.5	406.4	392.1	456.9	2.9	4	4.6	5.3	6	6.7	13	19.2	25.4	31.6	40.8	47.3	41.3	52.5	53.6	10	15.2	25.1	9.8	10.6	15.7
Deferred Revenue Non Current	-34.81	0	0	-47.5	-14	-226.9	-9.4	-13.7	-23.7	-32.1	-29.7	-29.6	-23.3	0	-13.5	0	0	-4.5	-1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	170.59	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	641.22	145.9	137.9	159.9	127.7	117.5	109.4	80.7	74.5	96.8	93.8	83	129.8	46.3	114	71.5	46.5	26.9	19.1	50.2	48.8	47.7	40.2	43.7	38.4	51.8	39.2	26.2	26.1	25.2	29.4	22.3	20
balance-sheet.row.total-non-current-liabilities	3574.47	865	668	834.8	395.7	371.1	100.2	287.9	412.4	467.9	463.4	512.9	44.8	38.5	29.9	16.9	17.1	11.1	16.8	24.7	31.8	35.6	44	50.4	54.2	65.4	63.6	24.6	24.4	38.2	21.3	15.1	16.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	63.06	63.1	7.2	70.7	59.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	4589.19	1116.8	1110.3	1088.3	680	606.9	484.9	499.1	597.1	657	681.2	692.7	175.6	147.1	161	109.8	114.8	93.1	104.9	112.6	127.6	136	128.1	129.8	142.7	134.5	142	98.2	70.8	87.3	69.9	53.6	54.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2.03	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0	0	0	0
balance-sheet.row.retained-earnings	1186.18	253.2	202.4	158	78.5	161.4	266.9	289.9	316.2	420.4	433.3	398.2	400.8	373.6	334.6	309.5	302.2	315.8	302.8	233.8	322.3	293	264.6	234.3	230.7	211.8	190.8	215.7	182.7	146.8	113.2	81.7	57
balance-sheet.row.accumulated-other-comprehensive-income-loss	-116.99	-30.4	-26	-29.5	-45.1	-30.4	-19	-32.9	-35	-21.7	1.4	5.4	9.1	9.5	5.9	3.3	4.8	-0.2	-2.8	-0.7	-6.5	-13.5	-16.4	-17.6	-13.1	-19.6	-19.2	-12.4	-74.4	-60.9	-45.1	-34.2	-25.3
balance-sheet.row.other-total-stockholders-equity	2448.37	594.7	572.5	602.7	553.2	536.3	504	482	438.3	427	404.3	365	324.9	302.7	252.3	226.8	186.9	163.8	141.4	121.8	-36.3	-56.6	-11.7	-1.5	-11.5	29.4	22.8	21.7	108.7	107.3	92.7	79.2	58.9
balance-sheet.row.total-stockholders-equity	3519.59	818	749.4	731.7	587.1	667.9	752.4	739.6	720	826.1	839.6	769.2	735.1	686.1	593.1	539.9	494.2	479.6	441.6	355.1	279.7	223.2	236.8	215.5	206.4	221.9	194.7	225.3	217	193.2	160.8	126.7	90.6
balance-sheet.row.total-liabilities-and-stockholders-equity	8108.79	1934.8	1859.7	1819.9	1267.1	1274.8	1237.3	1238.7	1317.1	1483.1	1520.8	1461.9	910.6	833.3	754.1	649.7	609	572.7	546.5	467.8	407.4	359.2	364.9	345.3	349.1	356.4	336.7	323.5	287.8	280.5	230.7	180.3	144.8
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	3519.59	818	749.4	731.7	587.1	667.9	752.4	739.6	720	826.1	839.6	769.2	735.1	686.1	593.1	539.9	494.2	479.6	441.6	355.1	279.7	223.2	236.8	215.5	206.4	221.9	194.7	225.3	217	193.2	160.8	126.7	90.6
balance-sheet.row.total-liabilities-and-total-equity	8108.79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	2.88	1.1	0	-6	-3.9	-4.4	-4	-4	-7.1	-581.9	-609.1	-596.6	-211.6	0	-211.6	0	0	0	0	0	0	0	38.6	33	18.8	37	50.5	44.6	0	0	0	0	0
balance-sheet.row.total-debt	3163.65	765.9	773.6	707.6	382.5	350.1	253.7	314.6	408	427.9	437.7	480.1	3.8	4.9	21.7	6	12.4	28.9	39.2	45.8	58.3	70.6	72.1	69.7	74.2	59.1	71.1	29.5	18.6	33.4	14.3	13.6	24.1
balance-sheet.row.net-debt	2048.48	481.4	514.1	515.3	245.2	180.8	73.5	175.1	292.9	267.2	245.2	301	-225.1	-191.8	-119.9	-150.7	-121.2	-200.4	-211.5	-140	-59.9	20.7	37.2	28.3	12.9	2.8	49.3	21.2	5.2	29.2	-1.9	3.3	21.2

现金流量表

在 Haemonetics Corporation 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 1.150 的转变。该公司最近通过发行 7.02 扩大了股本，与上一年相比出现了-1.370 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-143788000.000. 与上一年相比， 0.665 发生了变化. 在同一时期，公司记录了 93.31, 1.61 和 -9.63，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-7.02 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -15.74，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
cash-flows.row.net-income	126.57	115.4	43.4	79.5	76.5	55	45.6	-26.3	-55.6	16.9	35.1	38.8	0.8	0.7	58.4	59.3	52	49.1	69.1	39.6	29.3	28.4	30	7.2	19	21.1	-24.8	33	35.9	33.6	31.5	24.8	18
cash-flows.row.depreciation-and-amortization	93.43	93.3	97.7	84.3	110.3	109.4	89.2	89.7	90	86.1	81.7	65.5	50	48.1	43.2	36.5	31.2	27.5	25.1	27.6	30.1	28.4	25.6	24.5	24.9	24.6	22.9	12.3	13.1	13.7	10.7	8.5	7
cash-flows.row.deferred-income-tax	22.11	4.8	5	-19.9	-7	13.4	-5.8	-6.8	-1	4.2	-0.2	0.6	5.9	5.8	2.6	1.6	-0.9	0	-0.3	4	1.3	4	-0.7	2.1	-1.7	-7.3	-0.3	3.6	-3.2	0.9	0	3.4	0.4
cash-flows.row.stock-based-compensation	27.97	25.6	24.4	25.5	20.5	17.2	13	9.2	6.9	14.1	13.1	11	9.3	10.8	10.3	10.2	0.2	0	0	0	0	0	0	0	0	-14.7	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-79.41	25.5	-15.2	-59.7	-84.6	-62.8	76.5	-1	-20.1	-3.5	0.2	-41.4	-15.5	-19	4.1	5.1	-10.7	-8.4	-14.4	-0.5	14.1	-14.9	-25.7	5.9	4.1	10.1	-15.4	-22.1	8.9	-32.7	-13.6	-0.8	-6.4
cash-flows.row.account-receivables	-27.79	-24.4	-35	44.1	18.9	-38.1	5.1	3.2	-10.3	8.8	6.2	-38.1	-10.5	-3.9	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-44.47	30.8	24.3	-38.9	-84.7	-39.3	14.4	-1.6	12.8	-16.9	-12.7	-18.7	-32.5	-2.6	-1.7	-11.2	-2.9	-8.5	-5.5	-4.7	9.3	-5.5	-18.3	6.4	-1.8	2.5	-14.7	-0.9	-0.2	-13.5	-10.6	1.1	-6.7
cash-flows.row.account-payables	18.84	39.8	7.6	-56.4	-17.3	17.7	0	0	0	12.7	3.6	21.6	22.5	-17	12.5	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-25.98	-20.6	-12.2	-8.5	-1.4	-3.1	57	-2.6	-22.6	4.6	6.8	15.4	27.6	-12.5	1.4	16.3	-7.8	0.1	-8.9	4.2	4.9	-9.5	-7.4	-0.5	5.9	7.6	-0.7	-21.2	9.1	-19.2	-3	-1.9	0.3
cash-flows.row.other-non-cash-items	6.61	8.5	16.9	-0.9	42.5	27.1	1.8	94.9	101.6	9.4	9.5	10.6	65.7	77.7	12.1	3.7	6.1	15.4	6.1	0.5	-0.3	-2.2	3.1	21.2	7.2	-14.8	38	-0.1	0.1	0.1	-1.6	0	-0.2
cash-flows.row.net-cash-provided-by-operating-activities	197.28	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-68.53	-110.2	-96.5	-37	-48.8	-119	-74.8	-76.1	-102.4	-122.2	-73.6	-62.2	-53.2	-46.7	-56.3	-56.4	-57.8	-41.5	-36.8	-17.5	-13.9	-13.5	-21.6	-30.5	-23.3	-22.5	-20.4	-32	-19.7	-24.9	-22.9	-17.6	-11.4
cash-flows.row.acquisitions-net	-243.78	-2	8.1	-390.2	-25.2	2.8	9	0	-3	0	-32.7	-535.2	0	-6.4	-77.8	-6	-46.9	-32.5	0	-5	0	0	-10.5	-26.6	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	15.81	-33.2	0	0	0	0	0	0	0	0	0	-1	0	0	0	0	0	0	0	-49.8	0	-11.7	-69.9	-47.4	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	23.73	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.5	0	44.3	66.5	49.7	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-54.57	1.6	2	1.8	16.8	0	2.8	0	-101.8	0	-73.2	-60.2	1	1.5	1.8	2.4	1.8	2.8	4.7	3.3	6	0.4	2.2	4.6	-6.8	29.2	-26.6	0	-6.2	-5.2	-1.3	0	-7
cash-flows.row.net-cash-used-for-investing-activites	-327.34	-143.8	-86.3	-425.4	-57.2	-116.1	-63	-73.3	-104.8	-121.8	-105.8	-596.4	-52.2	-51.6	-132.3	-60	-102.8	-71.1	-32.1	19.4	-7.9	19.5	-33.2	-50.1	-30.1	6.7	-47	-32	-25.9	-30.1	-24.2	-17.6	-18.4
cash-flows.row.debt-repayment	-337	-9.6	-17.5	-81.9	-13.1	-266.9	-61	-93.4	-20	-9.6	-38	-0.9	-0.8	0	-0.8	-6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	7.27	7	6.5	-3.2	12	13.4	0	0	0	0	0	0	3.7	0	0	0	17.2	14.9	15.1	26.2	18.1	4.8	13.5	14.7	8.5	6.4	3.1	4.7	2.9	1.8	2.4	1.2	7.6
cash-flows.row.common-stock-repurchased	-5.88	-75	0	0	-175	-160	-100	0	-61	-39	0	-50	-50	-50	-40	-60	-75	-40	0	0	0	-50.2	-26.9	-4.7	-39.7	0	-5.6	-15.8	-8.9	-15.7	-0.1	0	-2
cash-flows.row.dividends-paid	0	-7	0	0	-12	-13.4	0	0	0	0	0	0	-15.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-4.3
cash-flows.row.other-financing-activites	441.31	-15.7	-4.8	452.6	56.9	376.2	40.3	33	18.4	15.5	17.3	512.7	16.6	31.9	26.8	35.5	-15.5	-10.4	-3	-11.7	-17.3	-3.6	4	-5	13.4	-11.9	42.6	13.9	-13	16.1	-0.5	-12	-0.5
cash-flows.row.net-cash-used-provided-by-financing-activities	100.06	-100.4	-15.7	367.5	-131.2	-50.6	-120.6	-60.4	-62.6	-33.2	-20.7	461.9	-30.5	-18.1	-14	-30.7	-73.2	-35.6	12.1	14.5	0.7	-49	-9.3	5	-17.8	-5.5	40.1	2.8	-19	2.2	1.8	-10.8	0.8
cash-flows.row.effect-of-forex-changes-on-cash	-0.02	-3.9	-3	4.2	-1.9	-3.3	3.9	-1.6	0	-4.1	0.4	-0.3	-0.5	1.3	0.5	-2.5	2.7	1.7	-0.8	1.2	0.8	0.8	0.1	-0.3	-0.5	-0.4	0	-2.6	-0.7	0.3	1.3	-0.2	0
cash-flows.row.net-change-in-cash	-30.02	25	67.2	55	-32	-10.8	40.6	24.4	-45.5	-31.8	13.3	-49.7	32.2	55.1	-15.2	23.2	-95.7	-21.4	64.9	106.3	68.2	15	-10.3	15.5	5	34.5	13.5	-5.1	9.2	-12	5.9	7.3	1.2
cash-flows.row.cash-at-end-of-period	1115.17	284.5	259.5	192.3	137.3	169.4	180.2	139.6	115.1	160.7	192.5	179.1	228.9	196.7	141.6	156.7	133.6	229.2	250.7	185.8	118.1	49.9	34.9	41.4	61.3	56.3	21.8	8.3	13.4	4.2	16.2	10.2	2.9
cash-flows.row.cash-at-beginning-of-period	1145.19	259.5	192.3	137.3	169.4	180.2	139.6	115.1	160.7	192.5	179.1	228.9	196.7	141.6	156.7	133.6	229.2	250.7	185.8	79.5	49.9	34.9	45.2	25.9	56.3	21.8	8.3	13.4	4.2	16.2	10.3	2.9	1.7
cash-flows.row.operating-cash-flow	197.28	273.1	172.3	108.8	158.2	159.3	220.3	159.7	121.9	127.2	139.5	85.1	115.3	123.5	130.7	116.4	77.7	83.6	85.6	71.2	74.6	43.7	32.2	61	53.5	33.7	20.4	26.7	54.8	15.6	27	35.9	18.8
cash-flows.row.capital-expenditure	-68.53	-110.2	-96.5	-37	-48.8	-119	-74.8	-76.1	-102.4	-122.2	-73.6	-62.2	-53.2	-46.7	-56.3	-56.4	-57.8	-41.5	-36.8	-17.5	-13.9	-13.5	-21.6	-30.5	-23.3	-22.5	-20.4	-32	-19.7	-24.9	-22.9	-17.6	-11.4
cash-flows.row.free-cash-flow	128.75	162.9	75.8	71.8	109.5	40.3	145.6	83.6	19.5	5	65.9	22.9	62.1	76.8	74.4	60	19.9	42.1	48.8	53.7	60.7	30.1	10.6	30.5	30.1	11.2	0	-5.3	35.1	-9.3	4.1	18.3	7.4

利润表行

Haemonetics Corporation 的收入与上期相比变化了 0.177%。据报告, HAE 的毛利润为 615.1。该公司的营业费用为 459.06，与上年相比变化了 5.829%. 折旧和摊销费用为 93.31，与上一会计期间相比变化了 0.052%. 营业费用报告为 459.06，显示5.829% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.932%. 营业收入为 156.03，与上年相比变化了0.932%. 净利润的变化率为 1.661%。去年的净收入为115.4.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
income-statement-row.row.total-revenue	1270.18	1168.7	993.2	870.5	988.5	967.6	903.9	886.1	909.7	910.4	938.5	892	727.8	676.7	645.4	597.9	516.4	449.6	419.7	383.6	364.2	337	320	293.9	277.9	282.1	285.8	309.8	278.2	262.4	248.4	216.3	176.4	157.3
income-statement-row.row.cost-of-revenue	598.29	553.6	487.7	472.6	504	550	492	507.6	503.8	476	470.1	463.9	358.6	321.5	307.9	289.7	258.7	222.3	199.2	185.7	192.1	182.3	165.1	126.9	121.7	124	127.1	137.8	110.5	103.9	94.2	88.8	78.5	0
income-statement-row.row.gross-profit	671.89	615.1	505.5	397.8	484.5	417.5	411.9	378.5	405.9	434.4	468.4	428.1	369.2	355.2	337.5	308.2	257.7	227.3	220.5	197.9	172.1	154.7	154.8	166.9	156.2	158.1	158.7	172	167.7	158.5	154.2	127.5	97.9	157.3
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	54.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	90.18	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	7.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	40	32.3	47.4	32.8	50.6	0	0	-8.1	87.7	5.4	1.7	-6.5	0	-1.9	13.3	0	0	-5.5	-26.4	-0.1	0	0	0	4.6	24.9	24.6	22.9	12.3	13.1	13.7	10.7	8.5	7	0
income-statement-row.row.operating-expenses	491.28	459.1	433.8	339.9	330.6	334	355.8	339.3	369.5	393.9	421	367.4	282.1	244.7	240.9	222.6	187.4	155.5	121.5	137.9	126.2	117.2	108.4	110.4	122.6	126.4	127.7	123.6	113.4	106.1	102.4	85.7	68	0
income-statement-row.row.cost-and-expenses	941.4	459.1	921.5	812.5	834.5	884	847.8	846.9	873.3	869.8	891.2	831.3	640.7	566.1	548.8	512.3	446.2	377.8	320.7	323.7	318.4	299.5	273.5	237.3	244.3	250.4	254.8	261.4	223.9	210	196.6	174.5	146.5	0
income-statement-row.row.interest-income	6.11	13	5.8	9.4	13.5	9.9	0	0	0	0	0	0	0	0.4	0.4	2	5.4	7.9	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	9.12	14.6	17.1	16.8	16.2	9.9	4.5	8.1	9.5	9.4	10.9	-54.7	-54.6	0	0.7	0.1	-9	0.1	-37	0	-0.9	-3.5	13.6	59.4	13.1	-5.9	74.9	-6.3	-4.1	-2.1	-1.7	1.6	1.6	0
income-statement-row.row.selling-and-marketing-expenses	7.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-17.07	-14.6	-17.1	14.9	-66.8	-9.9	8	-58.6	-80.3	-5.4	-1.7	-6.5	2.3	-0.8	-15	-2.5	2	-0.6	29.2	0.1	1	2.4	-7.9	-20.2	-6.9	5.1	-23	4	3.2	2	2.7	0.2	0.6	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	40	32.3	47.4	32.8	50.6	0	0	-8.1	87.7	5.4	1.7	-6.5	0	-1.9	13.3	0	0	-5.5	-26.4	-0.1	0	0	0	4.6	24.9	24.6	22.9	12.3	13.1	13.7	10.7	8.5	7	0
income-statement-row.row.total-operating-expenses	-17.07	-14.6	-17.1	14.9	-66.8	-9.9	8	-58.6	-80.3	-5.4	-1.7	-6.5	2.3	-0.8	-15	-2.5	2	-0.6	29.2	0.1	1	2.4	-7.9	-20.2	-6.9	5.1	-23	4	3.2	2	2.7	0.2	0.6	0
income-statement-row.row.interest-expense	9.12	14.6	17.1	16.8	16.2	9.9	4.5	8.1	9.5	9.4	10.9	-54.7	-54.6	0	0.7	0.1	-9	0.1	-37	0	-0.9	-3.5	13.6	59.4	13.1	-5.9	74.9	-6.3	-4.1	-2.1	-1.7	1.6	1.6	0
income-statement-row.row.depreciation-and-amortization	77.64	93.3	88.7	84.3	110.3	109.4	89.2	89.7	90	86.1	81.7	65.5	50	48.1	43.2	36.5	31.2	27.5	25.1	27.6	30.1	28.4	25.6	24.5	24.9	24.6	22.9	12.3	13.1	13.7	10.7	8.5	7	0
income-statement-row.row.ebitda-caps	258.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	170.19	156	80.8	58	153.9	83.5	56.2	-19.4	-44	40.5	47.3	56.4	88.8	110.5	83.3	85.6	70.3	62.7	99	59.9	45.9	37.5	36.4	13.4	33.6	31.7	31	48.4	54.3	52.4	51.8	41.8	29.9	157.3
income-statement-row.row.income-before-tax	161.08	141.4	63.6	72.9	87.2	73.6	59.6	-27.5	-53.5	31.2	36.4	49.9	89.5	110.1	81.3	85	77.3	72.3	106.9	59.8	45.8	38.6	38.5	17.3	27.3	32.6	4.5	50.7	55.2	52.5	50.8	40	27.7	0
income-statement-row.row.income-tax-expense	34.5	26	20.3	-6.6	10.6	18.6	14.1	-1.2	2.2	14.3	1.3	11.1	22.6	30.1	22.9	25.7	25.3	23.2	37.8	20.2	16.5	10.2	10.8	10.1	8.5	11.4	3.9	17.7	19.3	18.9	19.3	15.2	9.7	0
income-statement-row.row.net-income	126.57	115.4	43.4	79.5	76.5	55	45.6	-26.3	-55.6	16.9	35.1	38.8	66.9	80	58.4	59.3	52	49.1	69.1	39.6	29.3	28.4	30	7.2	19	21.1	-24.8	33	35.9	33.6	31.5	24.8	18	0